Management tracks

Cancer company Merrimack Pharmaceuticals Inc. (NASDAQ:MACK) named Richard Peters president and CEO, effective Feb. 6. He was SVP and head of global rare diseases at the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY).

Fibrosis and inflammation company Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) named Walid Abi-Saab CMO, effective March 1. He was group VP of global clinical development and therapeutic area head of gastrointestinal, endocrinology and metabolism at Shire plc (LSE:SHP; NASDAQ:SHPG)...